White Papers

White Papers | June 15, 2020
MIT CDOIQ Symposium 2019 Summary

Globally renowned data privacy expert Luk Arbuckle – co-author of Anonymizing Health Data (O’Reilly Media) – co-moderated this invite-only, half-day deep dive into the complex topic of bridging the ...
White Papers | June 12, 2020
A Privacy Governance Framework to Support De-identification

While technology is an important enabler of data de-identification, technology is not the end of the story.
White Papers | June 12, 2020
RWE and Risk: A Primer

Balancing the Demand for Deep Data with Patient Privacy. As pharma companies have become more sophisticated in their use of real-world evidence (RWE), ...
White Papers | June 12, 2020
Avoid the Blur of Data Masking

Learn the difference between data masking and de-identification. Often confused, data masking and de-identification are not synonymous terms when it comes to unlocking protected health information ...
White Papers | June 12, 2020
De-Identification of Unstructured Data

De-identifying Unstructured Data to Enable Health Analytics. According to one organization, 80 percent of medical record data will be unstructured within the next two years.
White Papers | June 12, 2020
Achieving Clinical Trials Transparency

Recent policy changes by Europe’s regulatory authority for drugs and devices has rekindled the pharmaceutical industry’s focus on clinical trials transparency.
White Papers | June 12, 2020
Specialty Pharmaceuticals and Patient Privacy

In the specialty pharmaceutical industry, patient privacy is crucial. Privacy can be a challenge for companies looking to gather and consolidate patient...
White Papers | June 18, 2025
10 Best Practices for ROI on HIPAA Expert Determination

The Health Insurance Portability and Accountability Act (HIPAA) requires de-identification experts to follow generally accepted statistical and scientific methods for addressing re-identification ...

Filter by Data Type

Categories